Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TCR2 Therapeutics Inc (TCRR)
NASDAQ:TCRR
Holding TCRR?
Track your performance easily
TCRR Stock Chart & Stats
Day’s Range$1.48 - $1.63
52-Week Range― - ―
Previous Close$1.57
Volume3.91M
Average Volume (3M)N/A
Market Cap
$58.11M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TCR2 Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TCRR FAQ
What was TCR2 Therapeutics Inc’s price range in the past 12 months?
Currently, no data Available
What is TCR2 Therapeutics Inc’s market cap?
Currently, no data Available
When is TCR2 Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TCR2 Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is TCR2 Therapeutics Inc overvalued?
According to Wall Street analysts TCR2 Therapeutics Inc’s price is currently Overvalued.
Does TCR2 Therapeutics Inc pay dividends?
TCR2 Therapeutics Inc does not currently pay dividends.
What is TCR2 Therapeutics Inc’s EPS estimate?
TCR2 Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TCR2 Therapeutics Inc have?
Currently, no data Available
What happened to TCR2 Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TCR2 Therapeutics Inc?
Among the largest hedge funds holding TCR2 Therapeutics Inc’s share is Baker Bros Advisors LP. It holds TCR2 Therapeutics Inc’s shares valued at 1M.
---
TCR2 Therapeutics Stock Smart Score
Company Description
TCR2 Therapeutics Inc
TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering T-cells for cancer therapy. The company offers cancer therapy, T-cell biology, Immunology and Molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded in May 2015 and is headquartered in Cambridge, MA.
---
TCRR Stock 12 Month Forecast
Average Price Target
―Apellis Pharmaceuticals
―
Bioxcel Therapeutics
―
Corvus Pharmaceuticals
―
GlycoMimetics
―
Best Analysts Covering TCRR
1 Year
1 Year Success Rate
4/13 ratings generated profit
1 Year Average Return
-37.24%
reiterated a buy rating 2 years ago
Copying Do Kim's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade.
---